Shared associations of nonatherosclerotic, large-vessel, cerebrovascular arteriopathies: Considering intracranial aneurysms, cervical artery dissection, moyamoya disease and fibromuscular dysplasia

Current Opinion in Neurology

Volumn 26, Issue 1, 2013, Pages 13-28

  Southerland, Andrew M ^a,b   Meschia, James F ^c   Worrall, Bradford B ^a,b,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

aneurysm; arteriopathy; artery dissection; fibromuscular dysplasia; genetic; moyamoya

Indexed keywords

BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CERVICAL ARTERY DISSECTION; COGNITIVE DEFECT; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; ETHNICITY; FIBROMUSCULAR DYSPLASIA; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; INTRACRANIAL ANEURYSM; MOYAMOYA DISEASE; PHENOTYPE; PHYSICAL DISABILITY; PREVALENCE; REVIEW; SUBARACHNOID HEMORRHAGE;

COGNITION DISORDERS; FIBROMUSCULAR DYSPLASIA; HUMANS; INCIDENCE; INTRACRANIAL ANEURYSM; MOYAMOYA DISEASE; PREVALENCE; VASCULAR DISEASES;

EID: 84872924291     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32835c607f     Document Type: Review

References (221)

1. Cheung N, Liew G, Lindley RI, et al. Retinal fractals and acute lacunar stroke. Ann Neurol 2010; 68:107-111.
2. Moran C, Phan TG, Srikanth VK. Cerebral small vessel disease: a review of clinical, radiological, and histopathological phenotypes. Int J Stroke 2012; 7:36-46.
3. Rost NS, Rahman RM, Biffi A, et al. White matter hyperintensity volume is increased in small vessel stroke subtypes. Neurology 2010; 75:1670-1677.
4. WHO. WHO STEPS stroke manual: the WHO STEPwise approach to stroke surveillance. Geneva: WHO Press; 2006.
5. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24:35-41.
6. Ay H, Benner T, Arsava EM, et al. A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke 2007; 38:2979-2984.
7. Schievink WI, Mokri B, Michels VV, Piepgras DG. Familial association of intracranial aneurysms and cervical artery dissections. Stroke 1991; 22:1426-1430.
8. Schievink WI, Limburg M, Oorthuys JW, et al. Cerebrovascular disease in Ehlers-Danlos syndrome type IV. Stroke 1990; 21:626-632.
9. Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010; 47:476-485.
10. Ruigrok YM, Rinkel GJ, Wijmenga C. Genetics of intracranial aneurysms. Lancet Neurol 2005; 4:179-189.
11. Schievink WI, Bjornsson J, Piepgras DG. Coexistence of fibromuscular dysplasia and cystic medial necrosis in a patient with Marfan's syndrome and bilateral carotid artery dissections. Stroke 1994; 25:2492-2496.
12. Callewaert BL, Willaert A, Kerstjens-Frederikse WS, et al. Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families. Hum Mutat 2008; 29:150-158.
13. McConnell RS, Rubinsztein DC, Fannin TF, et al. Autosomal dominant polycystic kidney disease unlinked to the PKD1 and PKD2 loci presenting as familial cerebral aneurysm. J Med Genet 2001; 38:238-240.
14. Regalado ES, Guo DC, Villamizar C, et al. Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms. Circ Res 2011; 109:680-686.
15. van de Laar IM, van der Linde D, Oei EH, et al. Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. J Med Genet 2012; 49:47-57.
16. Grange DK, Balfour IC, Chen SC, Wood EG. Familial syndrome of progressive arterial occlusive disease consistent with fibromuscular dysplasia, hypertension, congenital cardiac defects, bone fragility, brachy-syndactyly, and learning disabilities. Am J Med Genet 1998; 75:469-480.
17. Schievink WI, Bjornsson J, Parisi JE, Prakash UB. Arterial fibromuscular dysplasia associated with severe alpha 1-antitrypsin deficiency. Mayo Clinic Proc 1994; 69:1040-1043.
18. Schievink WI, Meyer FB, Parisi JE, Wijdicks EF. Fibromuscular dysplasia of the internal carotid artery associated with alpha1-antitrypsin deficiency. Neurosurgery 1998; 43:229-233; discussion 33-34.
19. Schievink WI, Puumala MR, Meyer FB, et al. Giant intracranial aneurysm and fibromuscular dysplasia in an adolescent with alpha 1-antitrypsin deficiency. J Neurosurg 1996; 85:503-506.
20. Bofinger A, Hawley C, Fisher P, et al. Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia. J Hum Hypertens 2000; 14:91-94.
21. Solder B, Streif W, Ellemunter H, et al. Fibromuscular dysplasia of the internal carotid artery in a child with alpha-1-antitrypsin deficiency. Dev Med Child Neurol 1997; 39:827-829.
22. Bergen AA, Plomp AS, Schuurman EJ, et al. Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet 2000; 25:228-231.
23. Defillo A, Nussbaum ES. Intracranial aneurysm formation in siblings with pseudoxanthoma elasticum: case report. J Neurosurg Sci 2010; 54:105-107.
24. Brandt T, Morcher M, Hausser I. Association of cervical artery dissection with connective tissue abnormalities in skin and arteries. Front Neurol Neurosci 2005; 20:16-29.
25. Isotalo PA, Guindi MM, Bedard P, et al. Aortic dissection: a rare complication of osteogenesis imperfecta. Canadian J Cardiol 1999; 15:1139-1142.
26. Bober MB, Khan N, Kaplan J, et al. Majewski osteodysplastic primordial dwarfism type II (MOPD II): expanding the vascular phenotype. Am J Med Genet Part A 2010; 152A:960-965.
27. Yamauchi T, Tada M, Houkin K, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 2000; 31:930-935.
28. Koc F, Yerdelen D, Koc Z. Neurofibromatosis type 1 association with moyamoya disease. Int J Neurosci 2008; 118:1157-1163.
29. Volonghi I, Frigerio M, Mardighian D, et al. Grange syndrome: an identifiable cause of stroke in young adults. Am J Med Genet Part A 2012; 158A:2894-2898.
30. Molloy ES, Langford CA. Vasculitis mimics. Curr Opin Rheumatol 2008; 20:29-34.
31. Plaisier E, Gribouval O, Alamowitch S, et al. COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Engl J Med 2007; 357:2687-2695.
32. Alamowitch S, Plaisier E, Favrole P, et al. Cerebrovascular disease related to COL4A1 mutations in HANAC syndrome. Neurology 2009; 73:1873-1882.
33. Plaisier E, Chen Z, Gekeler F, et al. Novel COL4A1 mutations associated with HANAC syndrome: a role for the triple helical CB3[IV] domain. Am J Med Genet Part A 2010; 152A:2550-2555.
34. Parkin JD, San Antonio JD, Pedchenko V, et al. Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in pheno-types in inherited diseases affecting basement membranes. Hum Mutat 2011; 32:127-143.
35. Lanfranconi S, Markus HS. COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review. Stroke 2010; 41:e513-e518.
36. Volonghi I, Pezzini A, Del Zotto E, et al. Role of COL4A1 in basement-membrane integrity and cerebral small-vessel disease. The COL4A1 stroke syndrome. Curr Med Chem 2010; 17:1317-1324.
37. Weng YC, Sonni A, Labelle-Dumais C, et al. COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage. Ann Neurol 2012; 71:470-477.
38. Escamilla F, Espigares A, Hervas R, et al. Fibromuscular dysplasia with moyamoya phenomenon in a patient with Alport's syndrome. A type IV collagen disorder. Revista de neurologia 2000; 30:736-740.
39. Kashtan CE, Segal Y, Flinter F, et al. Aortic abnormalities in males with Alport syndrome. Nephrol Dial Transplant 2010; 25:3554-3560.
40. Xin B, Jones S, Puffenberger EG, et al. Homozygous mutation in SAMHD1 gene causes cerebral vasculopathy and early onset stroke. Proc Natl Acad Sci USA 2011; 108:5372-5377.
41. Ramesh V, Bernardi B, Stafa A, et al. Intracerebral large artery disease in Aicardi-Goutieres syndrome implicates SAMHD1 in vascular homeostasis. Develop Med Child Neurol 2010; 52:725-732.
42. Thiele H, du Moulin M, Barczyk K, et al. Cerebral arterial stenoses and stroke: novel features of Aicardi-Goutieres syndrome caused by the Arg164X mutation in SAMHD1 are associated with altered cytokine expression. Hum Mutat 2010; 31:E1836-E1850.
43. Guo DC, Papke CL, Tran-Fadulu V, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet 2009; 84:617-627.
44. Milewicz DM, Kwartler CS, Papke CL, et al. Genetic variants promoting smooth muscle cell proliferation can result in diffuse and diverse vascular diseases: evidence for a hyperplastic vasculomyopathy. Genet Med 2010; 12:196-203.
45. Munot P, Saunders DE, Milewicz DM, et al. A novel distinctive cerebrovascular phenotype is associated with heterozygous Arg179 ACTA2 mutations. Brain 2012; 135:2506-2514.
46. Roder C, Peters V, Kasuya H, et al. Analysis of ACTA2 in European moyamoya disease patients. Eur J Paediatr Neurol 2011; 15:117-122.
47. Olsen DR, Fazio MJ, Shamban AT, et al. Cutis laxa: reduced elastin gene expression in skin fibroblast cultures as determined by hybridizations with a homologous cDNA and an exon 1-specific oligonucleotide. J Biol Chem 1988; 263:6465-6467.
48. Ronkainen A, Hernesniemi J. Chapter 62: familial vascular diseases of neurosurgical significance. In: Mohr JP, Choi DW, Grotta JC, Weir B, Wolf PA, editors. Stroke (4th edition): pathophysiology, diagnosis, and management. Philadelphia, PA: Elsevier Inc; 2004.
49. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med 1993; 329:332-342.
50. Loeys BL, Schwarze U, Holm T, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006; 355:788-798.
51. Dittrich R, Heidbreder A, Rohsbach D, et al. Connective tissue and vascular phenotype in patients with cervical artery dissection. Neurology 2007; 68:2120-2124.
52. Grond-Ginsbach C, Debette S. The association of connective tissue disorders with cervical artery dissections. Curr Mol Med 2009; 9:210-214.
53. Broderick JP, Sauerbeck LR, Foroud T, et al. The familial intracranial aneurysm (FIA) study protocol. BMC Med Genet 2005; 6:17.
54. Frosen J, Piippo A, Paetau A, et al. Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases. Stroke 2004; 35:2287-2293.
55. Vates GE, Zabramski JM, Spetzler RF, Lawton MT. Intracranial aneurysms. In: Mohr JP, Choi DW, Grotta JC, Weir B, Wolf PA, editors. Stroke (4th edition): pathophysiology, diagnosis, and management. Philadelphia, PA: Elsevier, Inc; 2004.
56. de Rooij NK, Linn FH, van der Plas JA, et al. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 2007; 78:1365-1372.
57. Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med 2006; 354:387-396.
58. Labovitz DL, Halim AX, Brent B, et al. Subarachnoid hemorrhage incidence among Whites, Blacks and Caribbean Hispanics: the Northern Manhattan Study. Neuroepidemiology 2006; 26:147-150.
59. Linn FH, Rinkel GJ, Algra A, van Gijn J. Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke 1996; 27:625-629.
60. Menghini VV, Brown RD Jr, Sicks JD, et al. Incidence and prevalence of intracranial aneurysms and hemorrhage in Olmsted County, Minnesota 1965 to 1995. Neurology 1998; 51:405-411.
61. Vlak MH, Algra A, Brandenburg R, Rinkel GJ. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol 2011; 10:626-636.
62. Eden SV, Meurer WJ, Sanchez BN, et al. Gender and ethnic differences in subarachnoid hemorrhage. Neurology 2008; 71:731-735.
63. Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003; 289:2673-2684.
64. Algra AM, Klijn CJ, Helmerhorst FM, et al. Female risk factors for subarachnoid hemorrhage: a systematic review. Neurology 2012; 79: 1230-1236.
65. Bruno A, Carter S, Qualls C, Nolte KB. Incidence of spontaneous subarachnoid hemorrhage among Hispanics and non-Hispanic whites in New Mexico. Ethn Dis 1997; 7:27-33.
66. Kissela B, Schneider A, Kleindorfer D, et al. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke 2004; 35:426-431.
67. Rinkel GJ. Natural history, epidemiology and screening of unruptured intracranial aneurysms. Rev Neurol 2008; 164:781-786.
68. Sarti C, Tuomilehto J, Salomaa V, et al. Epidemiology of subarachnoid hemorrhage in Finland from 1983 to 1985. Stroke 1991; 22:848-853.
69. Ingall T, Asplund K, Mahonen M, Bonita R. A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke 2000; 31:1054-1061.
70. International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: risk of rupture and risks of surgical intervention. N Engl J Med 1998; 339:1725-1733.
71. Wiebers DO, Whisnant JP, Huston J 3rd, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003; 362:103-110.
72. Huttunen T, von und zu Fraunberg M, Frosen J, et al. Saccular intracranial aneurysm disease: distribution of site, size, and age suggests different etiologies for aneurysm formation and rupture in 316 familial and 1454 sporadic eastern Finnish patients. Neurosurgery 2010; 66:631-638; discussion 8.
73. Sforza DM, Putman CM, Cebral Jr. Hemodynamics of cerebral aneurysms. Ann Rev Fluid Mech 2009; 41:91-107.
74. Boussel L, Rayz V, McCulloch C, et al. Aneurysm growth occurs at region of low wall shear stress: patient-specific correlation of hemodynamics and growth in a longitudinal study. Stroke 2008; 39:2997-3002.
75. Nixon AM, Gunel M, Sumpio BE. The critical role of hemodynamics in the development of cerebral vascular disease. J Neurosurg 2010; 112:1240-1253.
76. Larsson E, Labruto F, Gasser TC, et al. Analysis of aortic wall stress and rupture risk in patients with abdominal aortic aneurysm with a gender perspective. J Vasc Surg 2011; 54:295-299.
77. Locksley HB. Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations. Based on 6368 cases in the cooperative study. J Neurosurg 1966; 25:219-239.
78. Kassell NF, Torner JC, Haley EC Jr, et al. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 1990; 73:18-36.
79. Vermeij FH, Hasan D, Bijvoet HW, Avezaat CJ. Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid hemorrhage. Stroke 1998; 29:924-930.
80. Foroud T, Sauerbeck L, Brown R, et al. Genome screen to detect linkage to intracranial aneurysm susceptibility genes: the Familial Intracranial Aneurysm (FIA) study. Stroke 2008; 39:1434-1440.
81. Bor AS, Koffijberg H, Wermer MJ, Rinkel GJ. Optimal screening strategy for familial intracranial aneurysms: a cost-effectiveness analysis. Neurology 2010; 74:1671-1679.
82. Bilguvar K, Yasuno K, Niemela M, et al. Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet 2008; 40:1472-1477.
83. Deka R, Koller DL, Lai D, et al. The relationship between smoking and replicated sequence variants on chromosomes 8 and 9 with familial intra-cranial aneurysm. Stroke 2010; 41:1132-1137.
84. Foroud T, Koller DL, Lai D, et al. Genome-wide association study of intracranial aneurysms confirms role of anril and SOX17 in disease risk. Stroke 2012; 43:2846-2852.
85. Ozturk AK, Nahed BV, Bydon M, et al. Molecular genetic analysis of two large kindreds with intracranial aneurysms demonstrates linkage to 11q24-25 and 14q23-31. Stroke 2006; 37:1021-1027.
86. Worrall BB, Foroud T, Brown RD Jr, et al. Genome screen to detect linkage to common susceptibility genes for intracranial and aortic aneurysms. Stroke 2009; 40:71-76.
87. Yasuno K, Bilguvar K, Bijlenga P, et al. Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet 2010; 42:420-425.
88. Yasuno K, Bakircioglu M, Low SK, et al. Common variant near the endothelin receptor type A (EDNRA) gene is associated with intracranial aneurysm risk. Proc Natl Acad Sci USA 2011; 108:19707-19712.
89. Debette S, Leys D. Cervical-artery dissections: predisposing factors, diagnosis, and outcome. Lancet Neurol 2009; 8:668-678.
90. Zweifler RM, Silverboard G. Chapter 23: arterial dissections. In: Mohr JP, Choi DW, Grotta JC, Weir B, Wolf PA, editors. Stroke (4th edition): pathophysiology, diagnosis, and management. Philadelphia, PA: Elsevier, Inc; 2004.
91. Lee VH, Brown RD Jr, Mandrekar JN, Mokri B. Incidence and outcome of cervical artery dissection: a population-based study. Neurology 2006; 67:1809-1812.
92. Giroud M, Fayolle H, Andre N, et al. Incidence of internal carotid artery dissection in the community of Dijon. J Neurol Neurosurg Psychiatry 1994; 57:1443.
93. Debette S, Grond-Ginsbach C, Bodenant M, et al. Differential features of carotid and vertebral artery dissections: the CADISP study. Neurology 2011; 77:1174-1181.
94. Dittrich R, Rohsbach D, Heidbreder A, et al. Mild mechanical traumas are possible risk factors for cervical artery dissection. Cerebrovasc Dis 2007; 23:275-281.
95. Schievink WI, Debette S. Etiology of cervical artery dissections: the writing is in the wall. Neurology 2011; 76:1452-1453.
96. Callaghan FM, Luechinger R, Kurtcuoglu V, et al. Wall stress of the cervical carotid artery in patients with carotid dissection: a case-control study. Am J Physiol Heart Circ Physiol 2011; 300:H1451-H1458.
97. Caplan LR, Zarins CK, Hemmati M. Spontaneous dissection of the extracranial vertebral arteries. Stroke 1985; 16:1030-1038.
98. Metso AJ, Metso TM, Debette S, et al. Gender and cervical artery dissection. Eur J Neurol 2012; 19:594-602.
99. Debette S, Metso T, Pezzini A, et al. Association of vascular risk factors with cervical artery dissection and ischemic stroke in young adults. Circulation 2011; 123:1537-1544.
100. Arnold M, Pannier B, Chabriat H, et al. Vascular risk factors and morpho-metric data in cervical artery dissection: a case-control study. J Neurol Neurosurg Psychiatry 2009; 80:232-234.
101. Paciaroni M, Georgiadis D, Arnold M, et al. Seasonal variability in spontaneous cervical artery dissection. J Neurol Neurosurg Psychiatry 2006; 77:677-679.
102. Schievink WI, Wijdicks EF, Kuiper JD. Seasonal pattern of spontaneous cervical artery dissection. J Neurosurg 1998; 89:101-103.
103. Arnold M, Kappeler L, Georgiadis D, et al. Gender differences in spontaneous cervical artery dissection. Neurology 2006; 67:1050-1052.
104. Southerland AM. Age distribution by sex and clinical characteristic in cervical artery dissection [abstract]. In: American Academy of Neurology Annual Meeting, April 9-April 16, 2011, Honolulu, Hawaii; 2011.
105. Dittrich R, Nassenstein I, Bachmann R, et al. Polyarterial clustered recurrence of cervical artery dissection seems to be the rule. Neurology 2007; 69:180-186.
106. Nedeltchev K, Bickel S, Arnold M, et al. R2-recanalization of spontaneous carotid artery dissection. Stroke 2009; 40:499-504.
107. Baracchini C, Tonello S, Meneghetti G, Ballotta E. Neurosonographic monitoring of 105 spontaneous cervical artery dissections: a prospective study. Neurology 2010; 75:1864-1870.
108. Caso V, Paciaroni M, Bogousslavsky J. Environmental factors and cervical artery dissection. Front Neurol Neurosci 2005; 20:44-53.
109. Fullerton HJ, Johnston SC, Smith WS. Arterial dissection and stroke in children. Neurology 2001; 57:1155-1160.
110. Chen M, Caplan L. Intracranial dissections. Front Neurol Neurosci 2005; 20:160-173.
111. Anderson RM, Schechter MM. A case of spontaneous dissecting aneurysm of the internal carotid artery. J Neurol Neurosurg Psychiatry 1959; 22:195-201.
112. Volker W, Besselmann M, Dittrich R, et al. Generalized arteriopathy in patients with cervical artery dissection. Neurology 2005; 64:1508-1513.
113. Volker W, Dittrich R, Grewe S, et al. The outer arterial wall layers are primarily affected in spontaneous cervical artery dissection. Neurology 2011; 76:1463-1471.
114. Martin JJ, Hausser I, Lyrer P, et al. Familial cervical artery dissections: clinical, morphologic, and genetic studies. Stroke 2006; 37:2924-2929.
115. Brandt T, Hausser I, Orberk E, et al. Ultrastructural connective tissue abnormalities in patients with spontaneous cervicocerebral artery dissections. Ann Neurol 1998; 44:281-285.
116. Barbour PJ, Castaldo JE, Rae-Grant AD, et al. Internal carotid artery redundancy is significantly associated with dissection. Stroke 1994; 25:1201-1206.
117. Ben Hamouda-M'Rad I, Biousse V, Bousser MG, et al. Internal carotid artery redundancy is significantly associated with dissection. Stroke 1995; 26:1962.
118. Tzourio C, Cohen A, Lamisse N, et al. Aortic root dilatation in patients with spontaneous cervical artery dissection. Circulation 1997; 95:2351-2353.
119. Schievink WI, Mokri B, Piepgras DG, Kuiper JD. Recurrent spontaneous arterial dissections: risk in familial versus nonfamilial disease. Stroke 1996; 27:622-624.
120. Debette S, Markus HS. The genetics of cervical artery dissection: a systematic review. Stroke 2009; 40:e459-e466.
121. Pezzini A, Drera B, Del Zotto E, et al. Mutations in TGFBR2 gene cause spontaneous cervical artery dissection. J Neurol Neurosurg Psychiatry 2011; 82:1372-1374.
122. Debette S. Genetics of cervical artery dissection. In: Sharma P, Meschia JF, editors. Stroke genetics. London: Springer-Verlag; 2013. pp. 207-221.
123. Debette S, Metso TM, Pezzini A, et al. CADISP-genetics: an international project searching for genetic risk factors of cervical artery dissections. Int J Stroke 2009; 4:224-230.
124. Houkin K, Ito M, Sugiyama T, et al. Review of past research and current concepts on the etiology of moyamoya disease. Neurol Med Chir 2012; 52:267-277.
125. Suzuki J, Takaku A. Cerebrovascular 'moyamoya' disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969; 20:288-299.
126. Masuda J, Ogata J, Yamaguchi T. Chapter 25: moyamoya disease. In: Mohr JP, Choi DW, Grotta JC, Weir B, Wolf PA, editors. Stroke (4th edition): pathophysiology, diagnosis, and management. Philadelphia: Elsevier, Inc; 2004.
127. Nanba R, Kuroda S, Tada M, et al. Clinical features of familial moyamoya disease. Child Nerv Sys 2006; 22:258-262.
128. Uchino K, Johnston SC, Becker KJ, Tirschwell DL. Moyamoya disease in Washington State and California. Neurology 2005; 65:956-958.
129. Liu W, Hashikata H, Inoue K, et al. A rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians. Environ Health Prevent Med 2010; 15:94-104.
130. Kamada F, Aoki Y, Narisawa A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 2011; 56:34-40.
131. Krischek B, Kasuya H, Khan N, et al. Genetic and clinical characteristics of moyamoya disease in Europeans. Acta Neurochir Suppl 2011; 112: 31-34.
132. Shimojima K, Yamamoto T. ACTA2 is not a major disease-causing gene for moyamoya disease. J Hum Genet 2009; 54:687-688.
133. Mineharu Y, Takenaka K, Yamakawa H, et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry 2006; 77:1025-1029.
134. Takekawa Y, Umezawa T, Ueno Y, et al. Pathological and immunohistochem-ical findings of an autopsy case of adult moyamoya disease. Neuropathology 2004; 24:236-242.
135. Burke GM, Burke AM, Sherma AK, et al. Moyamoya disease: a summary. Neurosurg Focus 2009; 26:E11.
136. Weinberg DG, Arnaout OM, Rahme RJ, et al. Moyamoya disease: a review of histopathology, biochemistry, and genetics. Neurosurg Focus 2011; 30:E20.
137. Ikeda H, Sasaki T, Yoshimoto T, et al. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 1999; 64: 533-537.
138. Miskinyte S, Butler MG, Herve D, et al. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet 2011; 88:718-728.
139. Miyatake S, Miyake N, Touho H, et al. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 2012; 78:803-810.
140. Roder C, Peters V, Kasuya H, et al. Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients. Acta Neurochir 2010; 152:2153-2160.
141. Sakurai K, Horiuchi Y, Ikeda H, et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet 2004; 49:278-281.
142. Zafeiriou DI, Ikeda H, Anastasiou A, et al. Familial moyamoya disease in a Greek family. Brain Develop 2003; 25:288-290.
143. Meschia JF, Ross OA. Heterogeneity ofmoyamoya disease: after adecade of linkage, is there new hope for a gene? Neurology 2008; 70:2353-2354.
144. Mineharu Y, Liu W, Inoue K, et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 2008; 70:2357-2363.
145. Koizumi A, Kobayashi H, Liu W, et al. P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure. Environ Health Prev Med 2012. [Epub ahead of print]
146. Liu W, Morito D, Takashima S, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PloS One 2011; 6:e22542.
147. Herve D, Touraine P, Verloes A, et al. A hereditary moyamoya syndrome with multisystemic manifestations. Neurology 2010; 75:259-264.
148. Inoue TK, Ikezaki K, Sasazuki T, et al. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 2000; 15:179-182.
149. Han H, Pyo CW, Yoo DS, et al. Associations of moyamoya patients with HLA class I and class II alleles in the Korean population. J Korean Med Sci 2003; 18:876-880.
150. Hong SH, Wang KC, Kim SK, et al. Association of HLA-DR and-DQ genes with familial moyamoya disease in Koreans. J Korean Neurosurg Soc 2009; 46:558-563.
151. Kraemer M, Horn PA, Roder C, et al. Analysis of human leucocyte antigen genes in Caucasian patients with idiopathic Moyamoya angiopathy. Acta Neurochir 2012; 154:445-454.
152. Piechowski-Józwiak B, Bogousslavsky J. Chapter 26: cervicocephalic fibro-muscular dysplasia. In: Mohr JP, Choi DW, Grotta JC, Weir B, Wolf PA, editors. Stroke (4th edition): pathophysiology, diagnosis, and management. Philadelphia: Elsevier, Inc; 2004.
153. Schievink WI, Bjornsson J. Fibromuscular dysplasia of the internal carotid artery: a clinicopathological study. Clin Neuropathol 1996; 15:2-6.
154. Touze E, Oppenheim C, Trystram D, et al. Fibromuscular dysplasia of cervical and intracranial arteries. Int J Stroke 2010; 5:296-305.
155. Mettinger KL. Fibromuscular dysplasia and the brain. II. Current concept of the disease. Stroke 1982; 13:53-58.
156. Olin JW, Froehlich J, Gu X, et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation 2012; 125:3182-3190.
157. Kirton A, Holland M, Benseler S, et al. Fibromuscular dysplasia and childhood stroke [abstract]. International Stroke Conference; 3 March 2011; Los Angeles, CA. p. e97. Abstr. 184.
158. Cloft HJ, Kallmes DF, Kallmes MH, et al. Prevalence of cerebral aneurysms in patients with fibromuscular dysplasia: a reassessment. J Neurosurg 1998; 88:436-440.
159. de Bray JM, Marc G, Pautot V, et al. Fibromuscular dysplasia may herald symptomatic recurrence of cervical artery dissection. Cerebrovasc Dis 2007; 23:448-452.
160. Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med 2001; 344:898-906.
161. Sang CN, Whelton PK, Hamper UM, et al. Etiologic factors in renovascular fibromuscular dysplasia. A case-control study. Hypertension 1989; 14:472-479.
162. Mettinger KL, Ericson K. Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics. Stroke 1982; 13:46-52.
163. Grimbert P, Fiquer-Kempf B, Coudol P, et al. [Genetic study of renal artery fibromuscular dysplasia]. Arch Mal Coeur Vaiss 1998; 91:1069-1071.
164. Bigazzi R, Bianchi S, Quilici N, et al. Bilateral fibromuscular dysplasia in identical twins. Am J Kidney Dis 1998; 32:E4.
165. Rushton AR. The genetics of fibromuscular dysplasia. Arch Intern Med 1980; 140:233-236.
166. Pannier-Moreau I, Grimbert P, Fiquet-Kempf B, et al. Possible familial origin of multifocal renal artery fibromuscular dysplasia. J Hypertens 1997; 15:1797-1801.
167. Perdu J, Boutouyrie P, Bourgain C, et al. Inheritance of arterial lesions in renal fibromuscular dysplasia. J Hum Hypertens 2007; 21:393-400.
168. Boutouyrie P, Gimenez-Roqueplo AP, Fine E, et al. Evidence for carotid and radial artery wall subclinical lesions in renal fibromuscular dysplasia. J Hypertens 2003; 21:2287-2295.
169. Poloskey SL, Kim ES, Sanghani R, et al. Low yield of genetic testing for known vascular connective tissue disorders in patients with fibromuscular dysplasia. Vasc Med 2012. [Epub ahead of print]
170. Bofinger A, Hawley C, Fisher P, et al. Polymorphisms of the renin-angiotensin system in patients with multifocal renal arterial fibromuscular dysplasia. J Hum Hypertens 2001; 15:185-190.
171. Perdu J, Gimenez-Roqueplo AP, Boutouyrie P, et al. Alpha1-antitrypsin gene polymorphisms are not associated with renal arterial fibromuscular dysplasia. J Hypertens 2006; 24:705-710.
172. Marks SD, Gullett AM, Brennan E, et al. Renal FMD may not confer a familial hypertensive risk nor is it caused by ACTA2 mutations. Pediatr Nephrol 2011; 26:1857-1861.
173. Fleisher GR, Buck BE, Cornfeld D. Primary intimal fibroplasia in a child with Down's syndrome. Am J Dis Child 1978; 132:700-703.
174. Lancman M, Mesropian H, Serra P, Granillo R. Turner's syndrome, fibro-muscular dysplasia, and stroke. Stroke 1991; 22:269-271.
175. Kousseff BG, Gilbert-Barness EF. Vascular neurofibromatosis' and infantile gangrene. Am J Med Genet 1989; 34:221-226.
176. Angela Dalenberg, Mayo Clinic. A biorepository to identify genes associated with FMD. www.fmdsa.org/dynamic/files/Angela%20Mayo%20PDF%20 PPT.pdf. [accessed 2 November 2012]
177. ARCADIA/PROFILE (Assessment of Renal and Cervical Artery DysplasIA Register et PROgression of FIbromuscular Lesions) 2012. http://centre- hypertension.org/qui-sommes-nous/. [accessed 5 November 2012]
178. Schievink WI, Mokri B, Piepgras DG. Angiographic frequency of saccular intracranial aneurysms in patients with spontaneous cervical artery dissection. J Neurosurg 1992; 76:62-66.
179. Wiebers DO, Mokri B. Internal carotid artery dissection after childbirth. Stroke 1985; 16:956-959.
180. Mokri B, Sundt TM Jr, Houser OW, Piepgras DG. Spontaneous dissection of the cervical internal carotid artery. Ann Neurol 1986; 19:126-138.
181. Rubinstein SM, Peerdeman SM, van Tulder MW, et al. A systematic review of the risk factors for cervical artery dissection. Stroke 2005; 36:1575-1580.
182. Feigin VL, Rinkel GJ, Lawes CM, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 2005; 36:2773-2780.
183. Van Merode T, Hick PJ, Hoeks AP, et al. Differences in carotid artery wall properties between presumed-healthy men and women. Ultrasound Med Biol 1988; 14:571-574.
184. Hansen F, Mangell P, Sonesson B, Lanne T. Diameter and compliance in the human common carotid artery: variations with age and sex. Ultrasound Med Biol 1995; 21:1-9.
185. Rajkumar C, Kingwell BA, Cameron JD, et al. Hormonal therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol 1997; 30:350-356.
186. Dockery F, Bulpitt CJ, Donaldson M, et al. The relationship between androgens and arterial stiffness in older men. J Am Geriatr Soc 2003; 51:1627-1632.
187. Calvet D, Boutouyrie P, Touze E, et al. Increased stiffness of the carotid wall material in patients with spontaneous cervical artery dissection. Stroke 2004; 35:2078-2082.
188. Guillon B, Tzourio C, Biousse V, et al. Arterial wall properties in carotid artery dissection: an ultrasound study. Neurology 2000; 55:663-666.
189. Cho BS, Roelofs KJ, Ford JW, et al. Decreased collagen and increased matrix metalloproteinase-13 in experimental abdominal aortic aneurysms in males compared with females. Surgery 2010; 147:258-267.
190. Ehrlichman LK, Ford JW, Roelofs KJ, et al. Gender-dependent differential phosphorylation in the ERK signaling pathway is associated with increased MMP2activityinrataorticsmoothmuscle cells. J Surg Res 2010; 160:18-24.
191. Cho BS, Woodrum DT, Roelofs KJ, et al. Differential regulation of aortic growth in male and female rodents is associated with AAA development. J Surg Res 2009; 155:330-338.
192. Guillon B, Peynet J, Bertrand M, et al. Do extracellular-matrix- regulating enzymes play a role in cervical artery dissection? Cerebrovasc Dis 2007; 23:299-303.
193. Lee TH, Hsu WC, Chen CJ, Chen ST. Etiologic study of young ischemic stroke in Taiwan. Stroke 2002; 33:1950-1955.
194. Arauz A, Hoyos L, Espinoza C, et al. Dissection of cervical arteries: long-term follow-up study of 130 consecutive cases. Cerebrovasc Dis 2006; 22:150-154.
195. Kwak JH, Choi JW, Park HJ, et al. Cerebral artery dissection: spectrum of clinical presentations related to angiographic findings. Neurointervention 2011; 6:78-83.
196. Chiu D, Shedden P, Bratina P, Grotta JC. Clinical features of moyamoya disease in the United States. Stroke 1998; 29:1347-1351.
197. Grau AJ, Brandt T, Buggle F, et al. Association of cervical artery dissection with recent infection. Arch Neurol 1999; 56:851-856.
198. Forster K, Poppert H, Conrad B, Sander D. Elevated inflammatory laboratory parameters in spontaneous cervical artery dissection as compared to traumatic dissection: a retrospective case-control study. J Neurol 2006; 253:741-745.
199. Guillon B, Berthet K, Benslamia L, et al. Infection and the risk of spontaneous cervical artery dissection: a case-control study. Stroke 2003; 34:e79-e81.
200. Genius J, Dong-Si T, Grau AP, Lichy C. Postacute C-reactive protein levels are elevated in cervical artery dissection. Stroke 2005; 36:e42-e44.
201. Hosoda Y. Pathology of so-called 'spontaneous occlusion of the circle of Willis'. Pathol Ann 1984; 19 (Pt 2):221-244.
202. Hosoda Y, Ikeda E, Hirose S. Histopathological studies on spontaneous occlusion of the circle of Willis (cerebrovascular moyamoya disease). Clin Neurol Neurosurg 1997; 99 (Suppl 2):S203-S208.
203. Ikeda U, Fujikawa H, Shimada K. Variant angina pectoris associated with moyamoya disease. Lancet 1998; 351:183-184.
204. Masuda J, Ogata J, Yutani C. Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease. Stroke 1993; 24:1960-1967.
205. Yamashita M, Oka K, Tanaka K. Histopathology of the brain vascular network in moyamoya disease. Stroke 1983; 14:50-58.
206. Bragin MA, Cherkasov AP. [Morphogenesis of fibromuscular dysplasia of the renal arteries (an ultrastructural study)]. Arkhiv Patologii 1979; 41:46-52.
207. Rexrode KM, Hennekens CH, Willett WC, et al. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 1997; 277:1539-1545.
208. Wieberdink RG, Poels MM, Vernooij MW, et al. Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam Study. Arterioscler Thromb Vasc Biol 2011; 31:2982-2989.
209. Welch KM. Reviewof the SPARCL trial and its subanalyses. Curr Atheroscler Rep 2009; 11:315-321.
210. Yano K, Reed DM, MacLean CJ. Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. Stroke 1989; 20:1460-1465.
211. Bonaventure A, Kurth T, Pico F, et al. Triglycerides and risk of hemorrhagic stroke vs. ischemic vascular events: the Three-City Study. Atherosclerosis 2010; 210:243-248.
212. Ohrlander T, Merlo J, Ohlsson H, et al. Socioeconomic position, comorbidity, and mortality in aortic aneurysms: a 13-year prospective cohort study. Ann Vasc Surg 2012; 26:312-321.
213. Le MT, Jamrozik K, Davis TM, Norman PE. Negative association between infra-renal aortic diameter and glycaemia: the Health in Men Study. Eur J Vasc Endovasc Surg 2007; 33:599-604.
214. Just M, Ribera M, Monso E, et al. Effect of smoking on skin elastic fibres: morphometric and immunohistochemical analysis. Br J Dermatol 2007; 156:85-91.
215. Rosenorn J, Ronde F, Eskesen V, Schmidt K. Seasonal variation of aneur-ysmal subarachnoid haemorrhage. Acta Neurochir 1988; 93:24-27.
216. Kloss M, Metso A, Pezzini A, et al. Towards understanding seasonal variability in cervical artery dissection (CeAD). J Neurol 2012; 259:1662-1667.
217. Hughes MA, Grover PJ, Butler CR, et al. A 5-year retrospective study assessing the association between seasonal and meteorological change and incidence of aneurysmal subarachnoid haemorrhage. Br J Neurosurg 2010; 24:396-400.
218. Pera J, Korostynski M, Krzyszkowski T, et al. Gene expression profiles in human ruptured and unruptured intracranial aneurysms: what is the role of inflammation? Stroke 2010; 41:224-231.
219. Marchese E, Vignati A, Albanese A, et al. Comparative evaluation of genome-wide gene expression profiles in ruptured and unruptured human intracranial aneurysms. J Biol Regul Homeost Agents 2010; 24:185-195.
220. Joo SP, Kim TS, Lee IK, et al. A genome-wide study of moyamoya-type cerebrovascular disease in the Korean population. J Korean Neurosurg Soc 2011; 50:486-491.
221. Grond-Ginsbach C, Chen B, Pjontek R, et al. Copy number variation in patients with cervical artery dissection. Eur J Hum Genet 2012; 20:1295-1299.